|
Re: Embargo
|
1
|
Zenith Epigenetics
|
Mar 31, 2017 11:27AM
|
|
Re: Enthusiasm? NOT!
|
3
|
Zenith Epigenetics
|
Oct 30, 2021 02:40PM
|
|
Re: Epigenetics and Coronavirus
|
6
|
Resverlogix Corp.
|
Mar 23, 2020 10:42AM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 04:57PM
|
|
Re: Epizyme market cap $750 mil USd
|
5
|
Zenith Epigenetics
|
Jun 18, 2017 09:32AM
|
|
Re: Equity financing
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 01:59PM
|
|
Re: Events
|
5
|
Zenith Epigenetics
|
Apr 25, 2017 10:03AM
|
|
Re: everything r v x is down 4% to around 24%
|
1
|
Resverlogix Corp.
|
Jan 27, 2021 03:10PM
|
|
Re: Exceptionally good news
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 11:37AM
|
|
Re: Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 19, 2021 10:39AM
|
|
Re: Exercise of rights / Red (-) Green (+)
|
3
|
Resverlogix Corp.
|
Oct 09, 2016 10:32AM
|
|
Re: Expectations for the AGM?
|
2
|
Zenith Epigenetics
|
Dec 10, 2020 12:18PM
|
|
Re: Expectations for the AGM?
|
6
|
Resverlogix Corp.
|
Dec 06, 2020 02:47PM
|
|
Re: Expectations for the AGM?
|
5
|
Zenith Epigenetics
|
Dec 10, 2020 01:52PM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
8
|
Resverlogix Corp.
|
May 03, 2021 06:40PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
4
|
Resverlogix Corp.
|
Aug 13, 2023 04:18PM
|
|
Re: find it interesting that RVXCF.....
|
4
|
Resverlogix Corp.
|
Nov 10, 2022 10:10AM
|
|
Re: find it interesting that RVXCF.....
|
4
|
Resverlogix Corp.
|
Nov 10, 2022 11:26AM
|
|
Re: find it interesting that RVXCF.....
|
1
|
Resverlogix Corp.
|
Nov 10, 2022 12:24PM
|
|
Re: find it interesting that RVXCF.....
|
7
|
Resverlogix Corp.
|
Nov 09, 2022 02:31PM
|
